BridgeMD
New treatment option for Comorbidities and Coexisting Conditions
Official title eCardiacRehab - a Hybrid Patient-Centered eHealth Programme
ClinicalTrials.gov ID: NCT07590635
What this study is testing
- What it's testing
- The overall aim of eCardiacRehab trial is to meet rehabilitation needs of patients with coronary artery disease (CAD) regardless of their access to traditional place-based rehabilitation by developing and evaluating the efficacy and cost effectiveness of an interdisciplinary and comprehensive home-based hybrid programme. eCardiacRehab address patient- and system level challenges to increase access to cardiac rehabilitation (CR).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adult Norwegian (or Scandinavian) speaking patients (≥ 18 years) who have a Norwegian national identification number
- With coronary artery disease after percutaneous coronary intervention
- Living at home
- Have internet available
- Provide signed informed consent
You likely can't join if
- Patients with cognitive impairment that may interfere with the ability to comply with the study protocol
- Severe aortic stenosis
- Severe arrhythmias
- Expected lifetime less than one year as determined by study personnel
- Otherwise clinically unstable
- Not fully revascularized
See the full eligibility criteria
- Adult Norwegian (or Scandinavian) speaking patients (≥ 18 years) who have a Norwegian national identification number
- With coronary artery disease after percutaneous coronary intervention
- Living at home
- Have internet available
- Provide signed informed consent
- Patients with cognitive impairment that may interfere with the ability to comply with the study protocol
- Severe aortic stenosis
- Severe arrhythmias
- Expected lifetime less than one year as determined by study personnel
- Otherwise clinically unstable
- Not fully revascularized
- Awaits percutaneous coronary intervention or coronary artery bypass graft surgery
- Inability to comply with the study protocol due to any physical disability, somatic disease, or mental problems as determined by study personnel
The study team makes the final eligibility decision.
Where it's taking place
- Bergen, Norway
Compensation & support
Compensation likely.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bergen, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.